Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 861177 NEW YORK, NY

Position in AMRX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$4,063,917
+$964,349 QoQ
Shares Held
234,773
-5.9% QoQ
Ownership
0.074%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#76
of 311 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority Sole 48% Shared 0% None 52%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. AMRX ranks #15 (0.5% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMRX

Export CSV
24 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,063,917 234,773
2026-03-31 $3,099,568 249,362
2025-12-31 $3,063,474 243,133
2025-09-30 $2,341,287 233,895
2025-06-30 $3,805,791 470,432
2025-03-31 $2,806,929 334,956
2024-12-31 $2,521,884 318,420
2024-09-30 $1,818,368 218,554
2024-06-30 $1,680,994 264,724
2024-03-31 $220,758 36,429
2023-06-30 $263,225 84,912
2023-03-31 $118,026 84,912
2022-12-31 $168,974 84,912
2022-09-30 $171,519 84,912
2022-06-30 $314,769 98,985
2022-03-31 $412,765 98,985
2021-12-31 $474,136 98,985
2021-09-30 $528,577 98,985
2021-06-30 $506,801 98,985
2021-03-31 $585,166 86,949
2020-12-31 $409,494 89,605
2020-09-30 $444,313 114,514
2020-06-30 $545,085 114,514
2020-03-31 $406,211 116,728